Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesA Limited Sampling Schedule to Estimate Individual Pharmacokinetic Parameters of Fludarabine in Hematopoietic Cell Transplant Patients
Clinical Cancer Research, 08/20/09
Salinger DH et al. – These are essential tools for prospective pharmacodynamic studies seeking to determine if clinical outcomes are related to F–ara–A pharmacokinetics in patients receiving i.v. fludarabine in the ambulatory clinic.
Related Articles
The Effect of Imatinib on Cytomegalovirus Reactivation in Hematopoietic Cell Transplantation
Clinical Infectious Diseases, 11/10/09
Relevance Score: 82%%
Generation of donor natural killer cells from CD34+ progenitor cells and subsequent infusion after HLA-mismatched allogeneic hematopoietic cell transplantation: a feasibility study
Bone Marrow Transplantation, 11/05/09
Relevance Score: 82%%
Prolonged isolated red blood cell transfusion requirement after allogeneic blood stem cell transplantation: identification of patients at risk
Transfusion, 12/02/09
Relevance Score: 81%%
Allogeneic hematopoietic stem cell transplantation (alloSCT) for chronic myeloid leukemia in the imatinib era; Evaluation of its impact within a subgroup of the randomized German CML Study IV
Blood, 11/20/09
Relevance Score: 81%%
Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation
Bone Marrow Transplantation, 11/19/09
Relevance Score: 81%%
Today in BMT/SCT...keeping you current
Receive free subspecialty "5-minute updates" via email
Unpredictability of iv Busulfan pharmacokinetics in children undergoing hematopoietic stem cell transplant for advanced beta thalassemia: Limited toxicity with a dose adjustment policy
Biology of Blood and Marrow Transplantation, 12/09/09
High levels of B-cell activating factor during the peri-transplant period are associated with the reduced incidence of acute graft-versus-host disease following the myeloablative allogeneic stem cell transplantation
Biology of Blood and Marrow Transplantation, 12/09/09
Improved survival with inhibitory Killer Immunoglobulin Receptor (KIR) gene mismatches and KIR haplotype B donors after nonmyeloablative, HLA-haploidentical bone marrow transplantation
Biology of Blood and Marrow Transplantation, 12/09/09
Sponsor
Article Search
Sponsor
Sponsor